FAR1 and breast carcinoma: In addition, comparing to more malignant tumor progression of T3 and T4 stage, the expression levels of FAR1 were much lower in T1 and T2 stage according to tumor nude metastasis (TNM) subsets in breast cancers (Supplementary Fig. S4f).